Presenting clinical and biologic features of patients with HSγδTCL
Patient . | Age, y/sex . | PS . | LDH . | Hemoglobin, g/L . | WBC count, × 109/L . | PBALC count, × 109/L . | Monocyte count greater than 1 × 109/L . | Circulating myeloid precursor cells . | Platelet count, × 109/L . | Previous history . |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 30/M | 2 | ND | 150 | 2.8 | 0 | — | — | 72 | Malaria |
| 2 | 32/M | 2 | n | 126 | 6.8 | 0 | Yes | — | 63 | — |
| 3 | 23/M | 2 | n | 127 | 5.4 | 0 | — | — | 30 | — |
| 4 | 39/F | 0 | n | 113 | 2.3 | 0.1 | — | — | 120 | — |
| 5 | 58/F | 1 | n | 102 | 3.6 | 0 | — | Yes | 78 | — |
| 6 | 19/M | 2 | 4n | 144 | 25.7 | 1.5 | Yes | Yes | 80 | — |
| 7 | 21/M | 2 | n | 112 | 8.5 | 0.3 | Yes | Yes | 46 | Malaria |
| 8 | 16/M | 1 | 2n | 84 | 3.2 | 0.2 | — | Yes | 68 | — |
| 9 | 43/M | 2 | 8n | 57 | 6.4 | 0.3 | — | Yes | 88 | Kidney transplantation |
| 10 | 34/M | 1 | 2n | 81 | 6.8 | 0 | — | — | 76 | Hodgkin disease |
| 11 | 48/M | 1 | n | 89 | 0.9 | 0.1 | — | Yes | 166 | Kidney transplantation |
| 12 | 16/F | 0 | 2n | 92 | 1.8 | 0 | — | — | 55 | Lupus erythematosus |
| 13 | 28/M | 1 | n | 74 | 1.2 | 0 | — | — | 121 | — |
| 14 | 41/M | 3 | 16n | 130 | 14.3 | 0.7 | — | Yes | 90 | — |
| 15 | 34/F | 1 | n | 124 | 7.9 | 0 | Yes | — | 84 | — |
| 16* | 44/M | 1 | n | 94 | 7.0 | 0 | Yes | — | 25 | — |
| 17 | 54/F | 1 | 2n | 97 | 2.7 | 0 | — | — | 116 | — |
| 18 | 27/M | 1 | 2n | 106 | 1.4 | 0.1 | — | — | 109 | Kidney transplantation |
| 19 | 50/M | 1 | 2n | 105 | 3.9 | 0 | — | — | 100 | — |
| 20 | 50/F | 1 | 2n | 98 | 0.9 | 0.3 | — | Yes | 90 | — |
| 21 | 36/M | 1 | 2n | 111 | 1.2 | 0.1 | — | — | 66 | Kidney transplantation |
Patient . | Age, y/sex . | PS . | LDH . | Hemoglobin, g/L . | WBC count, × 109/L . | PBALC count, × 109/L . | Monocyte count greater than 1 × 109/L . | Circulating myeloid precursor cells . | Platelet count, × 109/L . | Previous history . |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 30/M | 2 | ND | 150 | 2.8 | 0 | — | — | 72 | Malaria |
| 2 | 32/M | 2 | n | 126 | 6.8 | 0 | Yes | — | 63 | — |
| 3 | 23/M | 2 | n | 127 | 5.4 | 0 | — | — | 30 | — |
| 4 | 39/F | 0 | n | 113 | 2.3 | 0.1 | — | — | 120 | — |
| 5 | 58/F | 1 | n | 102 | 3.6 | 0 | — | Yes | 78 | — |
| 6 | 19/M | 2 | 4n | 144 | 25.7 | 1.5 | Yes | Yes | 80 | — |
| 7 | 21/M | 2 | n | 112 | 8.5 | 0.3 | Yes | Yes | 46 | Malaria |
| 8 | 16/M | 1 | 2n | 84 | 3.2 | 0.2 | — | Yes | 68 | — |
| 9 | 43/M | 2 | 8n | 57 | 6.4 | 0.3 | — | Yes | 88 | Kidney transplantation |
| 10 | 34/M | 1 | 2n | 81 | 6.8 | 0 | — | — | 76 | Hodgkin disease |
| 11 | 48/M | 1 | n | 89 | 0.9 | 0.1 | — | Yes | 166 | Kidney transplantation |
| 12 | 16/F | 0 | 2n | 92 | 1.8 | 0 | — | — | 55 | Lupus erythematosus |
| 13 | 28/M | 1 | n | 74 | 1.2 | 0 | — | — | 121 | — |
| 14 | 41/M | 3 | 16n | 130 | 14.3 | 0.7 | — | Yes | 90 | — |
| 15 | 34/F | 1 | n | 124 | 7.9 | 0 | Yes | — | 84 | — |
| 16* | 44/M | 1 | n | 94 | 7.0 | 0 | Yes | — | 25 | — |
| 17 | 54/F | 1 | 2n | 97 | 2.7 | 0 | — | — | 116 | — |
| 18 | 27/M | 1 | 2n | 106 | 1.4 | 0.1 | — | — | 109 | Kidney transplantation |
| 19 | 50/M | 1 | 2n | 105 | 3.9 | 0 | — | — | 100 | — |
| 20 | 50/F | 1 | 2n | 98 | 0.9 | 0.3 | — | Yes | 90 | — |
| 21 | 36/M | 1 | 2n | 111 | 1.2 | 0.1 | — | — | 66 | Kidney transplantation |
PS indicates performance status based on the Eastern Cooperative Oncology Group scale; WBC, white blood cell; PBALC, peripheral blood atypical lymphoid cell; n, normal value; ND, not done; and —, no.
Biologic features of hemophagocytic syndrome.